Publications by authors named "P Gurumurthy"

Claim this Profile
M
M2AI-CVD: Multi-modal AI approach cardiovascular risk prediction system using fundus images.
Premalatha Gurumurthy, Manjunathan Alagarsamy, Sangeetha Kuppusamy, Niranjana Chitra Ponnusamy

Network· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Surveillance of Mass Praziquantel and Albendazole Co-Administration in School Children from Southern Ethiopia: An Active Cohort Event Monitoring.
Tigist Dires Gebreyesus, Eyasu Makonnen, Tafesse Tadele, Habtamu Gashaw, Workagegnew Degefe, Parthasarathi Gurumurthy

J Clin Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study.
Adam M Fimbo, Omary Mashiku Minzi, Bruno P Mmbando, Parthasarathi Gurumurthy, Appolinary A R Kamuhabwa

Pharmaceuticals (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of medical conditions and medications received during pregnancy on adverse birth outcomes: A hospital-based prospective case-control study.
Krishna Undela, Parthasarathi Gurumurthy, M S Sujatha

Perspect Clin Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.
Christabel Khaemba, Abbie Barry, Wyckliff P Omondi, Kefa Bota, Sultani Matendechero, Parthasarathi Gurumurthy

Pharmaceuticals (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis